Abstract
Histone deacetylase inhibitors that increase histone acetylation on transformed cells are being investigated as unique anticancer drugs. The aim of this investigation was to evaluate an antiproliferative activity of the histone deacetylase inhibitors sodium butyrate (NaBT) and trichostatin A on 5 glioma cell lines, T98G, A172, U-87 MG, U-118 MG, and U-373 MG, with the examination of the altered expressions in p21 and gelsolin genes. Treatment with 5-mM NaBT and 40 ng/ml trichostatin A for 48 h caused more than a 50% growth inhibition in 5 cell lines as measured by cell proliferation assays. An increase in histone acetylation was confirmed in each cell line. After treatment with 5 mM NaBT, T98G, A172, and U118 cells undergo apoptosis as indicated by DNA ladder formation. Treatment with NaBT and trichostatin A also decreased DNA synthesis as examined by the fluorescence-activated cell sorting analysis in T98G and U87 cells. In addition to the suppression of cell growth, the up regulation of p21 and gelsolin expression was observed after treatment with NaBT, especially in T98G cells. Maximum expression of p21 and gelsolin was observed within 24 h after treatment. Results from our in vitro studies indicate that the treatment of hum...Continue Reading
Citations
Jul 12, 2005·Oncogene·Eun Hee KimKyeong Sook Choi
Mar 24, 2010·Neuro-oncology·Jun FuZhong-Ping Chen
Oct 9, 2007·Gynecologic Oncology·Mee Young AhnHyung Sik Kim
Apr 27, 2011·Journal of Cellular Physiology·Yu Kyung TakJoon Myong Song
Jul 3, 2015·Journal of Ophthalmology·Hua ZhangJi-Jing Pang
Jan 20, 2018·Molecular Neurobiology·Carlos Gustavo GarciaMarcelo Cossenza
Oct 28, 2015·Developmental Neurobiology·Hee Jae LeeEmanuel DiCicco-Bloom
Dec 9, 2008·Glia·Jing GaoXiaozhong Peng
Aug 28, 2009·Leukemia·B StamatopoulosL Lagneaux
Jul 13, 2007·Leukemia·N KatoM Imamura
Jan 10, 2008·Expert Review of Anticancer Therapy·Rimas V LukasM Kelly Nicholas
Oct 25, 2011·The Journal of Urology·Abdalla Ali DebHari K Koul
Jun 16, 2005·Molecular Pharmacology·Milin R AcharyaWilliam D Figg
Mar 24, 2004·Integrative Cancer Therapies·Stanislaw R Burzynski
Aug 12, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Magdalena KusaczukMarzanna Cechowska-Pasko
Apr 30, 2003·Drugs in R&D·Stanislaw R BurzynskiMark Bestak
Nov 26, 2004·Drugs in R&D·Stanislaw R BurzynskiMarc Bestak
Feb 9, 2005·Brain Tumor Pathology·Qiang LiKeiji Kawamoto
Nov 18, 2010·Expert Review of Anticancer Therapy·Rafael RoeslerGilberto Schwartsmann
Nov 3, 2006·Molecular Biology Reports·Qinlong LiWenliang Wang
Mar 20, 2019·Journal of Molecular Neuroscience : MN·Marienela Buendia DuqueRafael Roesler
Feb 21, 2007·Journal of Neuro-oncology·Hasan C UgurRona S Carroll
Jan 25, 2012·Journal of Neuro-oncology·K BajboujR Schneider-Stock
Sep 2, 2008·Cancer Research·Naoki WakimotoH Phillip Koeffler
Dec 24, 2005·Molecular Cancer Therapeutics·Xiao-Nan LiChing C Lau
May 30, 2006·Molecular Cancer Therapeutics·Ilker Y EyüpogluIngmar Blümcke
Dec 24, 2005·Molecular Cancer Therapeutics·Michal Entin-MeerDaphne Adele Haas-Kogan
Feb 4, 2014·Life Sciences·Wenzhong YangVed Chauhan
May 10, 2021·Bioorganic Chemistry·Xiuhong WeiFengyuan Che
Jul 22, 2004·Experimental Cell Research·V ChopinX Le Bourhis
Sep 21, 2017·Chemical Research in Toxicology·Maha S Al-Keilani, Nour A Al-Sawalha